Science Market Update

UCSF Receives $185M Donation for New Neuroscience Research Institute

Posted by Laura Braden on Mon, May 02, 2016

The University of California, San Francisco is one of the most well-funded research institutions in the country, comprised of hundreds of life scientists conducting cutting-edge research who continuously publish important research results. Thanks to a generous donation, the university will be expanding its research space over the next few years.  

(Image courtesy of Payton Chung via Wikimedia Commons)

Sandy and Joan Weill have recently announced a donation of $185 million to UCSF to create a new neuroscience institute on the UCSF Mission Bay campus, called the Weill Institute for Neurosciences. The institute will be housed in a soon-to-be-built $316 million facility, providing 270,000 square feet for research and outpatient services where medical practitioners and researchers can collaborate on projects.

Read More

Tags: CA, Southwest, Neuroscience, SFVS, Biotechnology Vendor Showcase, UCSF, new Building, new funding, UC San Francisco Parnassus, funding news, 2016, Weill Institute for Neurosciences, Sandy and Joan Weill

UCSF Researchers Find Zika Virus Linked to Microcephaly

Posted by Katheryn Rein on Thu, Apr 28, 2016

A link between the Zika virus and microcephaly has finally been proven by researchers at the University of California, San Francisco, ending the pervasive question sparked earlier this year.

Read More

Tags: CA, University of California San Francisco, California, SFVS, Stem Cell, UCSF, virus, Neurons, pregnancy, microcephaly, zika

UCSF Granted $20M for HIV Research Institute

Posted by Laura Braden on Mon, Jan 11, 2016

Since HIV/AIDS emerged as a global health problem in the 1980's, researchers have been diligently working to create new treatments and vaccines for the disease. Currently, there is no cure for the disease, and treatments can only suppress it. Because of its severity and broad reach, scientists around the world receive substantial funding each year to study this virus in order to gain a more thorough understanding and better combat it. Now, thanks to an award from the Foundation for AIDS Research (amfAR), researchers at the University of California, San Francisco will be able to study the virus in a new $20 million institute, located on the Mission Bay campus, for the next five years.
Read More

Tags: CA, University of California San Francisco, HIV, AIDS Research, Southwest, San Francisco, SFVS, Biotechnology Vendor Showcase, UCSF, UCSF Mission Bay, New research center, 2016

7 Top UCSF Scientists Receive NIH Research Awards

Posted by Robert Larkin on Tue, Dec 15, 2015

Seven researchers from the University of California, San Francisco have received “high-risk, high-reward” grants for biomedical research.

Read More

Tags: CA, University of California San Francisco, Medical Research, cancer research, California, Biomedical Reearch, San Francisco, SFVS, Research Funding, UCSF, UC San Francisco, NIH funding, Southwest Region, Mission Bay, UCSF Mission Bay, 2016, BioResearch Product Faire™

UCSF Bioresearch Unlocks NIH funding, New Understanding of Parkinson’s

Posted by Robert Larkin on Fri, May 08, 2015

In an effort to better understand the reason that deep-brain-stimulation (DBS) seems to work so well in Parkinson’s cases, researchers at University of California, San Francisco have recently conducted NIH-funded research, with illuminating results.

Read More

Tags: CA, California, 2015, disease research, SFVS, Research Funding, Biotechnology Vendor Showcase, UC San Francisco Parnassus, NIH grants

UCSF and OHSU Team Up to Tackle Childhood Leukemia

Posted by Robert Larkin on Mon, Apr 27, 2015

Scientists from UC San Francisco and Oregon Health & Science University (OHSU) have teamed up to tackle acute lymphoblastic leukemia (ALL), a blood cancer that typically affects children from two to five years old.

Read More

Tags: CA, Leukemia, Oregon Health and Science University, cancer research, Oregon, California, Pediatric Cancer Research, 2015, San Francisco, SFVS, BioResearch Product Faire Event, OR, UCSF, OHSU, Portland, UC San Francisco, Biotechnology Vendor Showcase Event

UCSF Receives $100M for Medical Centers, Research and Students

Posted by Robert Larkin on Mon, Mar 16, 2015

Already the nation’s leading university for medical research, UCSF continues to expand thanks to a generous and recent donation.

Read More

Tags: CA, Life Science Funding, 2015, San Francisco, SFVS, Research Funding, Biotechnology Vendor Showcase, UC San Francisco, San Francisco at Mission Bay, new medical buildings

UCSF Gifted $40M for Medical Center by "Angel" Investor

Posted by Robert Larkin on Fri, Feb 06, 2015

The UC San Francisco Medical Center is home to some of nation’s best doctors, industry-leading bio-researchers, and most recently, an angel. UCSF is proudly unveiling a new outpatient medical building- thanks to a $40 million gift from “angel investor” and philanthropist Ron Conway and his family.

Read More

Tags: CA, University of Californa San Francisco Mission Bay, 2015, San Francisco, SFVS, Research Funding, new medical buildings, Biotechnology Vendor Showcase Event

UCSF Bioresearchers Tap Into Potential of Unused DNA Bits

Posted by Sam Asher on Thu, Nov 06, 2014

One of the most baffling and crippling sorts of diseases are those that incite the immune system to attack the body. This class of diseases, known as autoimmune diseases, may seem like a very specialized and rare affliction, but in truth, it manifests itself in the form of several commonly known ailments like rheumatoid arthritis, asthma, type 1 diabetes, and multiple sclerosis. A new study from the University of California, San Francisco points to some of the causes and thus possible treatments for autoimmune diseases.

Read More

Tags: CA, University of California San Francisco, 2015, SFVS

$5.8 Million Awarded to New Collaborative Program to Study Genes to Find New Drug Targets

Posted by Laura Braden on Wed, Nov 05, 2014

There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines. 

Read More

Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!